CAMBRIDGE, Mass., Jan. 3 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will
webcast its corporate presentation at the 25th Annual JPMorgan Healthcare
Conference in San Francisco, California. Joshua Boger, Ph.D., Vertex's
President and Chief Executive Officer, will deliver the presentation on
Tuesday, January 9, 2007 at 2:00 p.m. PST (5:00 p.m. EST).
The presentation will be webcast live and may be accessed from the
'Events Calendar' of Vertex's website at http://www.vrtx.com. A replay of the
webcast will also be available on the Company's website until January 23,
2007. To ensure a timely connection, it is recommended that users register
at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is focused on viral diseases,
inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Vertex co-discovered the HIV protease inhibitor, Lexiva, with
GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
http://www.prnewswire.com/comp/938395.html /
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
